Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -1.54% | 74.76 | 1.0% | $1996.88m | |
| AMGN | Amgen, Inc. | -2.76% | 202.73 | 1.3% | $918.41m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.23% | 488.29 | 2.6% | $828.23m | |
| BIIB | Biogen, Inc. | 0.08% | 316.38 | 1.5% | $752.19m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.60% | 237.95 | 1.9% | $578.97m | |
| MRNA | Moderna, Inc. | -1.74% | 29.95 | 0.0% | $552.86m | |
| ILMN | Illumina, Inc. | -1.13% | 273.12 | 3.5% | $472.89m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.90% | 89.79 | 2.0% | $286.71m | |
| A | Agilent Technologies, Inc. | -1.50% | 71.58 | 1.6% | $233.14m | |
| EXAS | EXACT Sciences Corp. | -0.74% | 58.00 | 21.0% | $199.18m | |
| INCY | Incyte Corp. | 1.47% | 73.23 | 2.5% | $179.33m | |
| SGEN | Seattle Genetics, Inc. | 0.08% | 115.38 | 6.1% | $169.84m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.44% | 84.50 | 4.3% | $164.79m | |
| NVAX | Novavax, Inc. | -5.04% | 13.58 | 114.7% | $126.80m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.02% | 108.85 | 8.7% | $101.36m |
Company Profile
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.